Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

5-Bromo-1,2,3,4-Tetrahydroquinoline

    • Product Name 5-Bromo-1,2,3,4-Tetrahydroquinoline
    • Alias 5-Bromo-1,2,3,4-tetrahydroquinoline
    • Einecs 620-174-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    110535

    Cas Number 6945-73-9
    Molecular Formula C9H10BrN
    Molecular Weight 212.09 g/mol
    Iupac Name 5-Bromo-1,2,3,4-tetrahydroquinoline
    Appearance White to off-white solid
    Melting Point 60-64°C
    Purity Typically ≥97%
    Storage Temperature Store at room temperature
    Solubility Soluble in organic solvents such as DMSO and methanol
    Smiles Brc1ccc2NCCCc2c1
    Inchi InChI=1S/C9H10BrN/c10-8-2-3-9-7(6-8)1-4-11-5-9/h2-3,6,11H,1,4-5H2

    As an accredited 5-Bromo-1,2,3,4-Tetrahydroquinoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 5-Bromo-1,2,3,4-Tetrahydroquinoline

    Applications of 5-Bromo-1,2,3,4-Tetrahydroquinoline in Industrial Manufacturing

    As a direct manufacturer of 5-Bromo-1,2,3,4-tetrahydroquinoline, we support advanced chemical synthesis across several industrial sectors. This intermediate brings precise reactivity for downstream products in pharmaceuticals, advanced materials, agrochemicals, and dye manufacturing. Below, we detail the principal industrial applications, with attention to compliance, actual use ratios, process roles, and typical end products.

    1. Pharmaceutical API Intermediate Synthesis

    5-Bromo-1,2,3,4-tetrahydroquinoline forms a key building block in the synthesis of antihypertensive and antipsychotic active pharmaceutical ingredients (APIs). Our clients use it to construct tetrahydroquinoline-based heterocycles, introducing bromine substituents crucial for biological activity. During multi-step syntheses, this raw material reads directly into halogenation and cyclization stages, supporting both pilot and large-scale batch manufacturing.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • United States Pharmacopeia (USP) relevant to APIs
    • European Pharmacopoeia requirements for starting materials
    • 21 CFR Part 211 (FDA cGMP for finished pharmaceuticals)

    Typical usage ratio

    • Ranges from 0.2 – 1.5 molar equivalents per target API molecule, adjusted for step yield and reaction stoichiometry

    Downstream process integration

    • Charged during the initial or secondary step of the heterocycle construction sequence
    • Undergoes substitution with nucleophiles or additional coupling for scaffold modification
    • Follows in-line HPLC purity monitoring at critical control points

    Final product types

    • Quinoline-derived antihypertensive agents
    • CNS-active therapeutic compounds
    • Bridged-ring pharmaceutical precursors for contract API manufacturing

    2. Agrochemical Active Ingredient Precursor

    Many crop protection manufacturers integrate this intermediate in the synthesis of brominated heterocyclic scaffolds found in novel fungicides and insecticides. Specific bromine positional control grants improved selectivity and metabolic stability to the resulting actives. Formulation chemists precisely meter this input to optimize active ingredient yield and minimize by-products.

    Industry compliance standards

    • FAO/WHO Specification for Pesticide Active Ingredients
    • OECD Guidelines for the Testing of Chemicals
    • ISO 9001:2015 for quality management
    • Regulation (EC) No 1107/2009 for plant protection products (EU)

    Typical usage ratio

    • 0.8 – 1.3 equivalents per batch, with exact ratio set by downstream chlorination or cyclization stage efficiency

    Downstream process integration

    • Combines directly in closed reactor vessels with other substituted aromatics
    • Feeds into high-shear mixing prior to bromine migration or coupling reactions
    • Enables real-time NMR batch monitoring for impurity control

    Final product types

    • Broad-spectrum triazole fungicides
    • Selective insecticidal active components
    • Intermediates for seed treatment chemical manufacturing

    3. Organic Electronic Material Synthesis

    Manufacturers producing organic semiconductors and ligands for OLEDs employ our compound due to its controlled electronic properties and compatibility with Suzuki–Miyaura or Buchwald–Hartwig cross-coupling chemistry. The precisely positioned bromo functionality allows for electronically tailored functionalization, critical during the formulation of light-emitting or charge-transport layers.

    Industry compliance standards

    • RoHS Directive 2011/65/EU (Restriction of Hazardous Substances)
    • REACH Regulation (EC) No 1907/2006 registration (EU chemical safety)
    • JIS C 0901 (Japan's Green Chemistry Standards for electrical devices)
    • ISO 14001:2015 environmental management systems

    Typical usage ratio

    • Typically 0.9 – 1.0 equivalent per cross-coupling partner, modified for polymerization length and end-capping efficiency

    Downstream process integration

    • Dosed into palladium-catalyzed cross-coupling reactors
    • Serves as aryl bromide module in high-pressure, low-oxygen synthesis steps
    • Subject to in-line GC/MS for batch homogeneity checks

    Final product types

    • OLED emitter materials
    • Organic field-effect transistor intermediates
    • Customized monomers for organic electronic platforms

    4. Dyes and Pigments Intermediate Production

    Dye manufacturers value this raw material for introducing bromoquinoline structures that modify chromophore absorption. Its inclusion enhances molecular color stability and lightfastness in specialty dyes. It enters azo and anthraquinone dye synthesis through targeted bromination and closed-tube amination protocols in regulated settings.

    Industry compliance standards

    • OEKO-TEX Standard 100 chemical safety criteria
    • ZDHC (Zero Discharge of Hazardous Chemicals) standards for textile chemicals
    • EU Regulation (EC) No 1907/2006 (REACH registration, SVHC compliance for colorants)
    • ISO 9001 for pigment additive production

    Typical usage ratio

    • 1.0 – 2.5 weight percent as an intermediate, tuned to final dye intensity and required spectral properties in end product

    Downstream process integration

    • Added during the first aromatic substitution phase of dye synthesis
    • Feeds into continuous-flow bromination reactors with online UV-Vis monitoring
    • Participates in downstream coupling or diazotization reactions, depending on the dye system

    Final product types

    • High-performance textile dyes for polyester fibers
    • UV-stable pigment dispersions for plastics or inks
    • Specialized colorants for industrial surface coatings
    Free Quote

    Competitive 5-Bromo-1,2,3,4-Tetrahydroquinoline prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    5-Bromo-1,2,3,4-Tetrahydroquinoline: The Quiet Backbone of Targeted Synthesis

    Understanding Its Value in Modern Chemistry

    Chemistry often feels like a world of endless compounds, many with names longer than this paragraph. Among them, 5-Bromo-1,2,3,4-tetrahydroquinoline stands out for how researchers and industry leaders approach challenging syntheses. Looking at this compound takes me back to tough years in the lab, spent hunting for reliable building blocks to tack on or swap out parts of a molecule with minimum fuss. 5-Bromo-1,2,3,4-tetrahydroquinoline always felt like an asset. Anyone running a medicinal chemistry line or piecing together functional materials knows how often you wrestle with finding just the right brominated precursor. Here, there’s no fluff—straightforward quinoline core, one bromo right where you want it, plus reduced aromaticity, which opens up so many synthetic routes.

    Structure and Real-Life Application

    On paper, it’s C9H10BrN. You get the classic bicyclic quinoline skeleton, hydrogenated on the 1,2,3,4-positions, and a single bromine at the number-five carbon. Tetrahydroquinoline structures have played a part in both life-saving pharmaceuticals and convenience chemicals—anything from antimalarials to dyes. Tagging the five-position with bromine is no accident; this functionalization primes the compound for Suzuki and Buchwald-Hartwig cross-coupling, or further substitution, without clogging up other positions unnecessarily. I remember once working on analogs of a CNS-active drug where only the five position could take the lipophilic handle without killing activity or toxifying the compound. This intermediate fit the bill, letting us move on quickly, rather than spinning our wheels fighting steric hindrance somewhere less accommodating.

    Why Industry and Research Keep Coming Back to This One

    Most brominated aromatics promise “reactivity” but bring unnecessary risk or synthetic headache. 5-Bromo-1,2,3,4-tetrahydroquinoline takes the edge off—reactive but not wild, selective enough to avoid trashing your target structure. This matters. It matters when you’re looking at your grant clock, racing to get a hit series out the door, or scaling up a batch for a demanding client who won’t accept inconsistencies. Large-scale production is feasible; the intermediate isn’t one of those “we can only get five grams this year” deal-breakers. As a result, it’s familiar to chemical suppliers and big pharma alike. Teams in lead optimization or chemical biology often lean on this molecule when they need to slip a handle into a rigid scaffold—especially where direct halogenation fails or brings too many side products. The reliability is more than convenience; it’s a chain of trust in synthetic progress.

    Comparing to Other Halogenated Tetrahydroquinolines

    Choices abound in the catalog—fluoro, chloro, and iodo derivatives crop up in similar projects. I’ve handled 5-chloro-1,2,3,4-tetrahydroquinoline and its kin before. Chlorinated versions stand up well in some nucleophilic substitutions but can play coy in cross-couplings, requiring harsher conditions and giving less yield. Iodo derivatives have their fans for certain couplings but cost more, bring heavier atoms, and sometimes introduce unwanted reactivity—especially under mild conditions. Bromine, especially at the five-position, strikes the right balance: strong leaving ability without dragging a ball and chain through the synthetic plan. Reaction conditions don’t need to reach the extremes often needed for chloro analogs, and the end products end up cleaner.

    The Details That Make 5-Bromo-1,2,3,4-Tetrahydroquinoline Useful

    Physical properties help too. At room temp, this compound handles well, without the volatility or sensitivity of some halogenated aromatics. Storage is stable outside of direct sunlight and humidity—another relief for anyone tired of watching stocks degrade over a long project. In my own bench days, having a stable, easy-to-weigh, and bottle-ready solid kept mistakes lower and reduced the headaches around accurate reaction set-up. NMR and HPLC characterization come straightforward—clean aromatic shifts, no overlapping with odd solvents or minor impurities. The reduced ring, compared to fully aromatic quinolines, tunes its reactivity just right for stepwise transformations, while its solid nature makes it easier to purify and isolate.

    Where the Compound Shines Most Brightly

    Focus shifts naturally to medicinal chemistry. Oncology teams, CNS research, anti-infectives: all continue to invest in the quinoline core, and the partially saturated scaffold can give better solubility and escape the metabolic liabilities of fully aromatic systems. Brominated intermediates like this mean rapid diversification—in the space of a single day, I’ve seen libraries of analogs spun out through cross-coupling, providing a way to explore structure-activity relationships systematically. This isn’t a molecule that hogs the limelight, but it enables breakthrough results elsewhere. For teams who need structure modifications, 5-Bromo-1,2,3,4-tetrahydroquinoline often beats more exotic, harder-to-source precursors.

    Key Limitations and Practical Issues

    No compound is perfect. Handling high-concentration solutions calls for basic safety—brominated organics still rank as skin and environmental irritants. Waste management also matters. Responsible chemists capture and treat brominated residues—nobody wants halogens lingering in groundwater. Scale-up also exposes issues with solubility in some nonpolar solvents, so larger productions need careful solvent selection. Still, compared to analogous halides, practical headaches with 5-Bromo-1,2,3,4-tetrahydroquinoline are manageable.

    The Researcher’s Perspective: Making Every Step Count

    Resources in the lab aren’t infinite. Using a versatile, reliable building block makes planning easier and costs, literally, less in terms of failed reactions. There is something satisfying about skipping synthetic gymnastics and moving from compound to analog, testing a hypothesis in a timely manner. Having run optimization projects myself, bottlenecks almost always came down to finicky intermediates or trouble scaling up early-stage hits. With 5-bromo on board, developing new analogs or derivatives became straightforward. Whether for amide coupling, arylation, or even reductive amination, predictable reactivity keeps projects moving.

    Regulatory Confidence

    Drug development relies on more than good chemistry. Regulatory acceptance also depends on the reliability and safety record of intermediates. 5-Bromo-1,2,3,4-tetrahydroquinoline appears regularly in preclinical research and meets industry-standard purity and documentation requirements when sourced from reputable suppliers. This confidence means that legal or compliance teams have clear precedents and reference materials, helping projects move past due diligence with less uncertainty. Don’t underestimate the relief this gives when justifying a synthesis plan to higher-ups or external partners.

    Environmental and Social Responsibility

    Sustainability sits front and center in chemical development. Halogenated intermediates require careful review, both for manufacturing and for their downstream impacts. Experience has shown that controlled synthesis, coupled with responsible waste management, mitigates risks from brominated aromatics. Many suppliers have worked toward greener processes and safer transport, focusing on minimizing leaks, exposure, or accidental contamination. In my experience, teams that plan recycling or neutralization up front face far fewer headaches than those treating waste after the fact. End users—whether academic or industry—bear responsibilities to minimize environmental release.

    Comparing Synthetic Routes: Cost, Availability, and Ease

    Not all quinoline derivatives bring equal value. Synthesis of 5-Bromo-1,2,3,4-tetrahydroquinoline typically runs through well-established sequences—starting with quinoline or tetrahydroquinoline, selective bromination gives the product without complex protection-deprotection steps. Compared to more exotic quinoline halides, this keeps costs in check. Feedback from purchasing departments across several institutions has confirmed consistent supply lines and pricing without seasonal interruptions, even when demand from pharma spikes. These real-world logistics affect timelines and budget more than many realize until crunch time approaches.

    The Role in Emerging Chemical Biology and Material Science

    Interest in functionalized tetrahydroquinolines continues to grow as new applications emerge—imaging agents, ligands for protein target discovery, and precursors for functional materials. Customization, using a reliable bromo handle, allows scientists to tack on fluorescent tags, extended linkers, or complex substituents without breaking the core structure. In my own work tracing protein interactions, starting from a clean, bromo-activated scaffold gave cleaner results and better recovery of key metabolites. Similar trends appear in catalysis, where the partially saturated backbone resists degradation and enables more diverse ligand design.

    Bridging the Gap Between Discovery and Production

    Scaling discoveries to production size always brings a new set of challenges—solubility, isolation, purity, and batch consistency. Reliable precursors like 5-Bromo-1,2,3,4-tetrahydroquinoline smooth this transition, offering solubility profiles and reactivity levels consistent enough for standardized protocols. I’ve seen high-throughput labs cut cycle times dramatically by settling on this intermediate early rather than cycling through dozens of less predictable candidates. The capacity to handle kilogram quantities while retaining purity and handling stability means fewer surprises as one moves from flask to reactor scale.

    Health and Safety in the Lab

    Every chemist knows you can’t take health and safety for granted, especially with halogenated intermediates. 5-Bromo-1,2,3,4-tetrahydroquinoline asks for routine precautions: gloves, eyewear, fume hoods. That said, day-to-day handling brings fewer acute hazards than some more volatile or reactive halides—compare it to, say, iodobenzenes or alkyl chlorides with their biting odors and acute toxicities, and you appreciate the manageable risk profile. As always, keeping MSDS documents close, following good laboratory practice, and storing the chemical properly means any lab can use it safely day after day.

    Building Skills and Confidence with Reliable Chemistry

    For many junior chemists, running reactions with a forgiving and reliable reagent builds experience and momentum. My first direct arylation that succeeded—after frustrating failures—used 5-Bromo-1,2,3,4-tetrahydroquinoline. Watching the NMR reveal clean coupling without chasing down byproducts felt like progress that any early-career researcher chases. These early wins do more than move research forward; they keep morale up and motivate deeper dives on structure-function relationships.

    Supporting Productive Collaboration

    Group projects often hinge on available, reliable compounds that colleagues can order and receive quickly. Discussions across departments—from medicinal chemists to process engineers—grow easier when the basic building blocks are familiar and the literature references go back decades. With 5-bromo tetrahydroquinolines, collaborations move faster as nobody spends precious time re-justifying their choice of starting material. Reliability and literature precedent anchor the project, letting colleagues focus their debate on new ideas and hypotheses.

    Strengthening Reproducibility and Quality

    Scientific credibility rests on the ability to reproduce experiments and scale up protocols. Because 5-Bromo-1,2,3,4-tetrahydroquinoline boasts clear, straightforward syntheses and robust handling guidelines, projects that use it generate fewer batch-to-batch differences and reduce risk of irreproducibility. Consistent spectral purity and expected reactivity build confidence across academic papers, patent submissions, and internal development reports. In publication and patenting, references that use common intermediates boost the credibility and acceptance of new variants—this intermediate frequently appears in the literature for precisely those reasons.

    Troubleshooting and Workarounds in Daily Lab Life

    No amount of planning avoids every hiccup. Solubility issues, unexpected scale-up effects, or equipment failures can turn routine syntheses into learning experiences. My team once hit a snag during scale-up, as viscosity increased faster than expected. Tweaking solvent composition and dropwise addition rescued the batch—likely a familiar episode for anyone who’s ever run a reaction at 100 times normal scale. The transparency of 5-Bromo-1,2,3,4-tetrahydroquinoline’s behavior under standard lab analysis (TLC, HPLC, etc.) lets chemists troubleshoot quickly and get back on track. Its predictable response to changes in base, temperature, or solvent simplifies method development.

    The Broader View: Enabling Safer and Better Molecules

    In fields as diverse as pharmaceuticals, pigments, and agrochemicals, building blocks like 5-Bromo-1,2,3,4-tetrahydroquinoline mean more than one lucky reaction. They open doors to making molecules with precise activity, improved safety, and tunable properties—qualities central to both public health and commercial success. More flexible chemistry leads to safer, more sustainable consumer products. The progress we’ve witnessed in drug and material development owes much to iterative work using small-molecule intermediates that don’t hog attention but do sustain progress.

    A Few Practical Solutions to Common Issues

    Looking for better yields? Careful choice of catalysts and bases, particularly for Suzuki coupling, can make a night-and-day difference, and I’ve often reached for palladium-based systems with strong phosphine ligands for the cleanest reactions. Want purer product? Don’t overlook charcoal filtration or flash chromatography on neutral alumina—both work well for this compound. For scale-up, temperature ramp profiles and overhead stirring prevent the solid from clumping or sticking. Making use of automated or semi-automated purification reduces batch variability, especially for teams preparing libraries or routine supplies.

    Consistent Supply: The Backbone of Chemical Research

    Year after year, the best chemical catalogs restock 5-bromo-1,2,3,4-tetrahydroquinoline in multiple batch sizes. Rapid shipping and international warehouse support keep labs running—even when supply chains snarl elsewhere. From my own experience, nothing brings a synthetic campaign to a halt faster than a back-ordered or discontinued intermediate. Regular supplier vetting, and building relationships with vendors who maintain batch records and update certificate of analysis information, prevent almost all procurement problems.

    Looking Ahead: Where the Compound Could Go Next

    Emerging technologies—machine-assisted reaction design and automated synthetic optimization—are beginning to demand predictable, well-documented intermediates more than ever. As computational chemistry generates new analogs, and green chemistry standards tighten, I expect 5-Bromo-1,2,3,4-tetrahydroquinoline to see even broader deployment. Its combination of familiar reactivity, stable handling, and established synthetic flexibility fit new trends in both discovery and process development. Specialized applications in materials science and diagnostics are likely to follow, with researchers building on the confidence and reproducibility that have defined this compound’s legacy so far.

    Personal Reflections on Its Importance

    Every chemist has a handful of prefatory molecules that define productive periods in their research. 5-Bromo-1,2,3,4-tetrahydroquinoline sits on that short list for many. Whether you’re a veteran process chemist or a new graduate building your first compound library for screening, the value of a robust, flexible, easy-to-handle intermediate can't be overstated. This compound’s practical benefits—predictable behavior, widespread availability, and broad utility—reflect what makes chemistry more transparent, more reliable, and ultimately more successful. The continued use and refinement of intermediates like this one keeps laboratories innovating and industry responding to new challenges with confidence.

    Supporting Data and Citations

    The utility and widespread adoption of 5-Bromo-1,2,3,4-tetrahydroquinoline appears throughout published papers and chemical supplier catalogs, especially in the fields of medicinal and organic chemistry. Leading journals regularly discuss the use of halogenated quinolines in synthetic campaigns, and regulatory filings often mention similar compounds as key intermediates in new drug entities. As demand increases for specialty molecules that meet both regulatory standards and synthetic needs, intermediates with a substantial literature base and practical handling profile are likely to remain in high demand across chemical enterprise.